Adults 18 to 39, any sex, with Visual Acuity. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Subjective Overall ComfortPrimary· 11 days Post fit
Subjective Overall Comfort was evaluated using the Contact Lens User Experience Comfort scores (CLUE). CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.
Group
Value
95% CI
Senofilcon A
58.65
± 18.685
Lotrafilcon B
59.44
± 16.458
Subjective Overall Quality of VisionPrimary· 11 days post fit
Subjective Overall quality of Vision was evaluated using the Contact Lens User Experience Comfort scores (CLUE). CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.
Group
Value
95% CI
Senofilcon A
55.60
± 16.490
Lotrafilcon B
58.71
± 14.035
Sponsor's own description
The primary objective of this study is to evaluate the clinical performance of two marketed silicone hydrogel contact lenses in an Indian population in the following areas: physiological characteristics, comfort characteristics and vision characteristics.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT05099380 — Validation of Senofilcon A With New UV / HEV Filter
· NA
· completed
NCT04901897 — Product Performance of a New Silicone Hydrogel Contact Lens
· NA
· completed
NCT03742271 — Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population
· NA
· completed
NCT03597178 — Contact Lens Insertion and Removal in a Senior Subject Demographic
· NA
· completed
NCT03556579 — The Effects of Contact Lenses With Experimental Dye on Visual Function
· NA
· completed
Other recruiting trials for Visual Acuity
Currently open trials in the same condition.
NCT07443215 — Evaluation of Effect of Scatter on Visual Performance
· NA
· recruiting
NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath
· NA
· active not recruiting
NCT07085533 — Natural History Study of Inherited Retinal Diseases
· recruiting
NCT07135180 — Exploring the Eye Care Benefits of Cordyceps Cicadae Across Different Age Groups
· NA
· active not recruiting
NCT04632901 — A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA)
· active not recruiting
Other Johnson & Johnson Vision Care, Inc. trials
Trials by the same sponsor.
NCT07443215 — Evaluation of Effect of Scatter on Visual Performance
· NA
· recruiting
NCT07174596 — Evaluation of Approved Contact Lenses
· NA
· completed
NCT07076160 — Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
· NA
· completed
NCT06967129 — Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process
· NA
· completed
NCT06864858 — Clinical Evaluation of Two Cosmetic Contact Lenses
· NA
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Vision Care, Inc.
Last refreshed: 19 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02394808.